Skip to main content
#1165
📊 PBMCs of IIM patients with myocarditis(n=4) showed distinct gene expression v controls(n=4) v IIM alone(n=4)

Caoilfhionn Connolly CaoilfhionnMD

1 year 9 months ago
#1165 📊 PBMCs of IIM patients with myocarditis(n=4) showed distinct gene expression v controls(n=4) v IIM alone(n=4)👇 💥 B-cell dysregulation may drive myocarditis in IIM 🎯Key immunological insights into🫀involvement in IIM #ACR24 @RheumNow @JuliePaikMD @jhrheumatology https://t.co/PceZUS929S
Plenary II: pregnancy in RA

When a treat to target approach is used to achieve remission, pregnancy rates nearly simil

Brian Jaros, MD Dr_Brian_MD

1 year 9 months ago
Plenary II: pregnancy in RA When a treat to target approach is used to achieve remission, pregnancy rates nearly similar to general population! Time to pregnancy less than half that of non-T2T comparators @RheumNow #ACR24 https://t.co/B9F9M8t9Kt
Infertility in women with RA 2x higher

Risk factors
- age
- disease activity
- use of NSAIDs
- use of pred >7.5mg/d

Jiha Lee JihaRheum

1 year 9 months ago
Infertility in women with RA 2x higher Risk factors - age - disease activity - use of NSAIDs - use of pred >7.5mg/day With T2T aiming for remission, fertility improves and becomes similar to the general population #ACR24 @RheumNow ABST#1647 https://t.co/B2Tx4dju4Z
Does psoriasis (Pso) affect radiographic progression in ankylosing spondylitis (AS)?
A study comparing radiographic spi

Antoni Chan MD (Prof) synovialjoints

1 year 9 months ago
Does psoriasis (Pso) affect radiographic progression in ankylosing spondylitis (AS)? A study comparing radiographic spine assessment in AS patients with and without Pso reveals no significant differences in structural lesions. Male gender is a key factor in structural… https://t.co/z34FjHtjEJ
Is cognitive impairment in SLE driven by cell exhaustion or aging?Abstract 1514 shows that SLE patients with cognitive

Akhil Sood MD AkhilSoodMD

1 year 9 months ago

Is cognitive impairment in SLE driven by cell exhaustion or aging? Abstract 1514 shows that SLE patients with cognitive impairment had higher levels of CD8+ (cell exhaustion) and lower levels of cell senescence markers. @RheumNow #ACR24 https://t.co/SzxTQt3oNY

#1350
🔬 Microbiome & RA: Impact on Disease Activity & Vascular Function

➡️ Salivary microbiome a/w arter

Caoilfhionn Connolly CaoilfhionnMD

1 year 9 months ago
#1350 🔬 Microbiome & RA: Impact on Disease Activity & Vascular Function ➡️ Salivary microbiome a/w arterial stiffness (AIx)(p 0.019) ➡️ Stool microbiome a/w DAS28-CRP(p 0.027) 🔴Key taxa👇identified for each; no common taxa for both disease activity & AIx. #ACR24 @RheumNow https://t.co/54Sumzzd27
Navigating Positive ANA: Leveraging AI for better triage

Abstract 1526: Markus et al. developed a machine learning mod

Akhil Sood MD AkhilSoodMD

1 year 9 months ago
Navigating Positive ANA: Leveraging AI for better triage Abstract 1526: Markus et al. developed a machine learning model to predict progression to SLE, utilizing diagnoses, meds, procedures, and labs collected 2 years before and 5 years after +ANA. @RheumNow #ACR24 https://t.co/2zzSH8Pb0e
What is the impact of social connections on lupus?

Abstract #1503: In an NYC SLE cohort, greater social integration and

Akhil Sood MD AkhilSoodMD

1 year 9 months ago
What is the impact of social connections on lupus? Abstract #1503: In an NYC SLE cohort, greater social integration and support correlated with less pain, depression, disability, and frailty, while loneliness was linked to worse outcomes. @RheumNow #ACR24 #SDoH https://t.co/5OCCExee06
Reason for consult: aortitis- evaluate for systemic causes

Abstract 1638: Kmetova et al highlight the promising clinic

Akhil Sood MD AkhilSoodMD

1 year 9 months ago
Reason for consult: aortitis- evaluate for systemic causes Abstract 1638: Kmetova et al highlight the promising clinical utility of calprotectin as a marker for clinically isolated aortitis @RheumNow #ACR24 https://t.co/2qPaAqWswG
17S19 session on steroid free future
@LesleyJacksonMD @EBRheum @BritAdlerMD

Is a (near) steroid free future for RA, AN

Eric Dein ericdeinmd

1 year 9 months ago
17S19 session on steroid free future @LesleyJacksonMD @EBRheum @BritAdlerMD Is a (near) steroid free future for RA, ANCA, Lupus #ACR24 @RheumNow
#1456
💥In a real-world UK PsA cohort, 25% had joint erosion @ diagnosis

➡️Mean disease duration 34mo. @ diagnos

Caoilfhionn Connolly CaoilfhionnMD

1 year 9 months ago
#1456 💥In a real-world UK PsA cohort, 25% had joint erosion @ diagnosis ➡️Mean disease duration 34mo. @ diagnosis ➡️Mean disability score = mod. to severe 💥Delay in diagnosis=poor outcomes ‼️Are we doing enough to catch PsA early? ? 🔑Earlier detection key #ACR @RheumNow
#1375🏋️‍♀️ Strength Training in RA

➡️ 12-week trial 28 ♀️
High-intensity(HIRT) v. Low-intensity+blo

Caoilfhionn Connolly CaoilfhionnMD

1 year 9 months ago
#1375🏋️‍♀️ Strength Training in RA ➡️ 12-week trial 28 ♀️ High-intensity(HIRT) v. Low-intensity+blood flow restriction(LIT-BFR) 🔴Equivalent gains:Lat-pulldown, biceps curl 🔴Knee extension:HIRT>LIT-BFR (non-significant) ✅ LIT-BFR: Alternative for RA sarcopenia #ACR24 @RheumNow
John Stone
Steroid-free AAV
CYCLOPS: steroid tox like “wallpaper on room”
WGET (ETN for GCA) - taper off by 6 mos -

Eric Dein ericdeinmd

1 year 9 months ago
John Stone Steroid-free AAV CYCLOPS: steroid tox like “wallpaper on room” WGET (ETN for GCA) - taper off by 6 mos - neg trial but started tapers RAVE - low doses 8-9 mg/d over 18 mos LoVAS - low dose steroid equally eff ADVOCATE - AVA one month taper, tox score #ACR24 @RheumNow https://t.co/C7eLK5UNPM
It's always so dispiriting to see PMR patients rack up steroid side effects in front of your eyes.

(the intense motivat

David Liew drdavidliew

1 year 9 months ago
It's always so dispiriting to see PMR patients rack up steroid side effects in front of your eyes. (the intense motivation to do better than pred for our PMR patients) #ACR24 @SattuiSEMD @RADoctor ABST0975 @RheumNow https://t.co/FTsvrTIt2F
#1474
🔬Severe PsA? Guselkumab (GUS) has promise!

➡️In bionaive pts with severe disease activity,
GUS v. PBO res

Caoilfhionn Connolly CaoilfhionnMD

1 year 9 months ago
#1474 🔬Severe PsA? Guselkumab (GUS) has promise! ➡️In bionaive pts with severe disease activity, GUS v. PBO resulted in: 🔴73% improvement in joints 🔴53% lower disease activity 🔴63% better PtGA by 2 years ➡️Rapid results by W2, sustained through W100. #ACR @RheumNow
×